These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 11453989

  • 1. Rapid and cooperative binding of factor XII to human umbilical vein endothelial cells.
    Schousboe I.
    Eur J Biochem; 2001 Jul; 268(14):3958-63. PubMed ID: 11453989
    [Abstract] [Full Text] [Related]

  • 2. Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells.
    Reddigari SR, Shibayama Y, Brunnée T, Kaplan AP.
    J Biol Chem; 1993 Jun 05; 268(16):11982-7. PubMed ID: 8505323
    [Abstract] [Full Text] [Related]

  • 3. Endothelial cells express a matrix protein which binds activated factor XII in a zinc-independent manner.
    Schousboe I.
    Thromb Haemost; 2006 Feb 05; 95(2):312-9. PubMed ID: 16493494
    [Abstract] [Full Text] [Related]

  • 4. Differential binding of factor XII and activated factor XII to soluble and immobilized fibronectin--localization of the Hep-1/Fib-1 binding site for activated factor XII.
    Schousboe I, Nystrøm BT, Hansen GH.
    FEBS J; 2008 Oct 05; 275(20):5161-72. PubMed ID: 18793325
    [Abstract] [Full Text] [Related]

  • 5. Binding of activated Factor XII to endothelial cells affects its inactivation by the C1-esterase inhibitor.
    Schousboe I.
    Eur J Biochem; 2003 Jan 05; 270(1):111-8. PubMed ID: 12492481
    [Abstract] [Full Text] [Related]

  • 6. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA.
    Thromb Haemost; 1999 Sep 05; 82(3):1033-40. PubMed ID: 10494760
    [Abstract] [Full Text] [Related]

  • 7. Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation.
    Mutch NJ, Waters EK, Morrissey JH.
    J Thromb Haemost; 2012 Oct 05; 10(10):2108-15. PubMed ID: 22905925
    [Abstract] [Full Text] [Related]

  • 8. Activation of the bradykinin-forming cascade on endothelial cells: a role for heat shock protein 90.
    Joseph K, Tholanikunnel BG, Kaplan AP.
    Int Immunopharmacol; 2002 Dec 05; 2(13-14):1851-9. PubMed ID: 12489799
    [Abstract] [Full Text] [Related]

  • 9. High molecular weight kininogen and factor XII binding to endothelial cells and astrocytes.
    Fernando LP, Natesan S, Joseph K, Kaplan AP.
    Thromb Haemost; 2003 Nov 05; 90(5):787-95. PubMed ID: 14597972
    [Abstract] [Full Text] [Related]

  • 10. Effect of neurotropin on the binding of high molecular weight kininogen and Hageman factor to human umbilical vein endothelial cells and the autoactivation of bound Hageman factor.
    Shibayama Y, Reddigari SR, Teruya M, Nakamura K, Fukunaga Y, Ienaga K, Nishikawa K, Suehiro S, Kaplan AP.
    Biochem Pharmacol; 1998 Apr 15; 55(8):1175-80. PubMed ID: 9719471
    [Abstract] [Full Text] [Related]

  • 11. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP, Joseph K.
    Adv Immunol; 2014 Apr 15; 121():41-89. PubMed ID: 24388213
    [Abstract] [Full Text] [Related]

  • 12. Factor XII does not initiate prekallikrein activation on endothelial cells.
    Røjkjaer R, Hasan AA, Motta G, Schousboe I, Schmaier AH.
    Thromb Haemost; 1998 Jul 15; 80(1):74-81. PubMed ID: 9684789
    [Abstract] [Full Text] [Related]

  • 13. Factor XII truncation accelerates activation in solution.
    de Maat S, Clark CC, Boertien M, Parr N, Sanrattana W, Hofman ZLM, Maas C.
    J Thromb Haemost; 2019 Jan 15; 17(1):183-194. PubMed ID: 30394658
    [Abstract] [Full Text] [Related]

  • 14. Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1.
    Joseph K, Shibayama Y, Ghebrehiwet B, Kaplan AP.
    Thromb Haemost; 2001 Jan 15; 85(1):119-24. PubMed ID: 11204562
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of contact activation by a kininogen peptide (HKH20) derived from domain 5.
    Nakazawa Y, Joseph K, Kaplan AP.
    Int Immunopharmacol; 2002 Dec 15; 2(13-14):1875-85. PubMed ID: 12494915
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.